Updated Vectibix prescribing information - MPR

Links shared publicly online about this topic.

  • 1,884
    total visits

Updated Vectibix prescribing information - MPR

empr.com

The FDA has approved revisions to the prescribing information of Vectibix (panitumumab), a human epidermal growth factor receptor (EGFr) inhibitor.

View full resource at empr.com

Tags: Colorectal Cancer Medication, FDA, Vectibix

  • Share

Most Recently Shared on July 20, 2009 at 4:11 pm By:

eMPR MPR

MPR News: Updated Vectibix prescribing information: The FDA has approved revisions to the prescribing i.. http://bit.ly/TMBRH

3 years ago...

MIMS Online | Facebook

facebook.com — “MIMS Online - Welcome to the MIMS page! Get regular prescribing updates and other interesting MIMS-related information here - General Information: MIMS publications are independently compiled by our editorial team and are widely used by healthcare professionals in particular general practitioners, pharmacists and nurse prescribers. - Description: MIMS, or the Monthly Index of Medical Specialities, has been providing healthcare professionals with information on prescription medicines every... | FView full resource at facebook.com

  • View Related
  • Share

Most Recently Shared on March 2, 2012 at 2:35 pm By:

mimsonline MIMS Online Medical Publisher

We’ve made some interesting changes to our Facebook page. Take a look at http://t.co/Wba2LYGE (preferably after you’ve finished lunch…)

1 month ago...

PharmaLive: Seattle Genetics Announces Updates to Adcetris Prescribing Information

pharmalive.com — “PharmaLive: Seattle Genetics Announces Updates to Adcetris Prescribing InformationView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on January 13, 2012 at 6:00 pm By:

pharmalive PharmaLive Pharma and Health News

Seattle Genetics Announces Updates to Adcetris Prescribing Information: http://t.co/mTYQjFW4

3 months ago...

Cushing's Help and Support

cushie.info — “Welcome to Cushing's Help and Support. This site provides information, support, RSS feeds, news, and education for people with Cushing's or other endocrine problems, their friends and families. Cushing's syndrome is a hormonal disorder caused by prolonged exposure of the body's tissues to high levels of cortisol. This website also deals with Thyroid Disorders, Addison's Disease, Adrenal Disorders, Cushing's Syndrome, Pituitary Disorders, Pituitary disease, Growth Hormone, Pheochromacytomas, FibrView full resource at cushie.info

  • View Related
  • Share

Most Recently Shared on November 10, 2011 at 6:30 pm By:

cushings MaryO Active Health Library and Patient Expert

Diabetes in Cushing syndrome: basic and clinical aspects http://t.co/5fWcLPil #cushings

5 months ago...

HealthSavers : Miraculous Magnesium

healthsavers.info — “Constantly updated research information on therapeutic nutritionals for congestive heart failure and all forms of cardiovascular disease - protocols for replacing routinely prescribed deadly drug regimens with research supported, pharmaceutical grade, physician recommended supplements.View full resource at healthsavers.info

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 11:28 pm By:

NurseForHealth
In Oct. of 2009, Sue became a Certified Natural Health Professional, and in 2011 became Certified as a Digestive Health Specialist through the Loomis Institute of Enzyme Nutrition, and is also a member of the American Holistic Nurses Association. Sue has a private practice in Green Bay, WI., but has the priviledge of having and serving clients in areas of Nova Scotia, Boston, Minnesota, West Virginia, and the Fox Valley area of WI. She maintains her current WI Nursing Licensure. We welcome you to contact us about cancer-fighting supplements used in Sue's treatment.
" /> Suzan Macco RN, CNHP, Loomis Digestive Health Specialist Nurse and Active Health Library

#Calcium tightens, #Magnesium relaxes... http://t.co/KWhWGbE

7 months ago...

News in Brief: Week of Aug. 22-26 -- AAFP News Now -- American Academy of Family Physicians

aafp.org — “This roundup includes the following news briefs: AstraZeneca Updates Prescribing Information for Asthma Drug; Report Shows More Children Covered by Medicare, CHIP; CMS Takes Steps to Expand Competitive Bidding Program; and Graham Center’s UDS Mapper Takes First Place at International Conference.View full resource at aafp.org

  • View Related
  • Share

Most Recently Shared on August 24, 2011 at 11:26 pm By:

Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease - Drugs.com MedNews

drugs.com — “Revised prescribing information reflects FDA guidance to update labeling for all drugs within ESA class HORSHAM, Pa., Janssen Products, LP, formerly Centocor OrView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 24, 2011 at 9:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Janssen Products, LP Modifies Prescribing Information for PROCRIT (Epoetin alfa) in Chronic Kidney Disease... http://bit.ly/m5idvC #drug

10 months ago...

U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose -- 80 mg -- and Updated Drug Interaction Information - Drugs.com MedNews

drugs.com — “Jun 8, 2011 - Merck (NYSE MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States fView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 8, 2011 at 8:08 pm By:

Drugs_Devices Drugs and Devices OW OW Health

U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose ... http://bit.ly/k3UOuv #drug

10 months ago...

FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl

fda.gov — “The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 6:06 pm By:

Glycosmedia Jim Health News

Updated Risk Evaluation & Mitigation Strategy to Restrict Access to Rosiglitazone-containing Medicines (FDA) http://1.usa.gov/lwECEi

11 months ago...

Up-to-date e-Rx guide includes new rules, incentives - ARRA News

mhanewsnow.typepad.com — “Guidelines for providers moving to e-prescribing have been updated to include rule changes and information on incentives. The American Medical Association, American Academy of Family Physicians, American College of Physicians, Medical Group Management Association, eHealth Initiative and Center for Improving Medication Management collaborated on the guide. Read more here.View full resource at mhanewsnow.typepad.com

  • View Related
  • Share

Most Recently Shared on April 29, 2011 at 4:12 pm By:

AmericanEHR Partners

blog.americanehr.com — “From a press release published April 26, 2011: Five partner organizations today issued an updated 2011 edition of A Clinician--™s Guide to Electronic Prescribing. This --how-to-- guide helps health care professionals make informed decisions about how and when to transition from paper to e-prescribing systems. First created in 2008, the...View full resource at blog.americanehr.com

  • View Related
  • Share

Most Recently Shared on April 27, 2011 at 10:16 pm By:

rsm2800 Robert S. Miller, MD Oncologist, Physician, Doctor, and Internist

AmericanEHR Partners Updated Guide to E-Prescribing http://goo.gl/ZzWlW Excellent, free 56 pg pdf by AAFP, ACP, MGMA et al

12 months ago...

February 2011

fda.gov — “Monthly Safety Labeling Changes includes 53 products with revisions to drug Prescribing Information.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 10:48 pm By:

RheumWATCH

rheumatology.org — “These issue updates are sent by fax/e-mail to Advocates and ACR leadership on the 15th of each month, keeping them informed about the ACR's efforts in Washington.View full resource at rheumatology.org

  • View Related
  • Share

Most Recently Shared on January 31, 2011 at 1:40 pm By:

ACRheum AmerCollRheumatology Health Organization and Rheumatology

Check out this month's RheumWATCH featuring info on physician payment rates for 2011, retroactive DXA payments & more: http://ow.ly/3MARf

1 year ago...

FDA: Aseptic Meningitis Risk With Use Of Seizure Drug Lamictal - QualityPoint Technologies

qualitypointtech.net — “The U.S. Food and Drug Administration warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection. The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk...View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 16, 2010 at 2:27 pm By:

MedicalFeed MedicalFeed Health News Feed

FDA: Aseptic Meningitis Risk With Use Of Seizure Drug Lamictal: The U.S. Food and Drug Administration warned that ... http://bit.ly/9WJ4v9

2 years ago...

Lamictal can cause aseptic meningitis: FDA

news-medical.net — “The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 13, 2010 at 4:51 pm By:

Meningitis_News News-Medical.Net Health News

Meningitis News: Lamictal can cause aseptic meningitis: FDA: The U.S. Food and Drug Administration today warned th... http://bit.ly/bNWNDT

2 years ago...

FDA warns Lamictal can cause aseptic meningitis

news-medical.net — “The U.S. Food and Drug Administration today warned that the drug Lamictal (lamotrigine), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation of the protective membranes (meninges) that cover the brain and spinal cord not caused by bacterial infection.The agency is working with the drug's manufacturer, GlaxoSmithKline, to update the prescribing information and patient medication guide to include this risk.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 13, 2010 at 8:34 am By:

NewsMedical News-Medical.Net Health News

FDA warns Lamictal can cause aseptic meningitis: The U.S. Food and Drug Administration today warned that the drug ... http://bit.ly/9JTYuF

2 years ago...

Advertisement